SCHEMBL22122003

SCHEMBL22122003

NCC#Cc1ccc(Br)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 4/20 0.60
CYP1A2 P05177 3/20 0.60
CYP3A4 P08684 3/20 0.60
CYP2C9 P11712 3/20 0.60
THPO P40225 1/20 0.60
BLM P54132 1/20 0.58
PMP22 Q01453 1/20 0.58
CYP2A6 P11509 4/20 0.46
CYP2E1 P05181 3/20 0.46
CYP2B6 P20813 3/20 0.46
CYP2D6 P10635 2/20 0.44
CYP2C8 P10632 1/20 0.42
PYCR1 P32322 1/20 0.40
HTR2A P28223 2/20 0.39
TAAR1 Q96RJ0 1/20 0.39
ALDH1A1 P00352 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
APP P05067 1/20 0.35
MAOB P27338 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL21803742 0.98 BLM (0.61) CYP2C19CYP1A2CYP3A4CYP2C9THPO
SCHEMBL6449000 0.87 CYP2C19 (0.75) CYP2C19CYP1A2CYP3A4CYP2C9THPO
SCHEMBL508102 0.78 PYCR1 (0.41) CYP2C19CYP1A2CYP3A4CYP2C9THPO
SCHEMBL2080824 0.76 CYP2C19 (0.60) CYP2C19CYP1A2CYP3A4CYP2C9THPO
SCHEMBL7038938 0.76 CYP2C19 (0.60) CYP2C19CYP1A2CYP3A4CYP2C9THPO
Hydrochloric Acid SCHEMBL25239520 0.76 BLM (0.64) CYP2C19CYP1A2CYP3A4CYP2C9THPO
SCHEMBL3451115 0.76 CYP2C19 (0.60) CYP2C19CYP1A2CYP3A4CYP2C9THPO
SCHEMBL797749 0.76 FFAR1 (0.40) CYP2C19CYP1A2CYP3A4CYP2C9THPO
SCHEMBL4621099 0.76 PYCR1 (0.40) CYP2C19CYP1A2CYP3A4CYP2C9THPO
SCHEMBL7573145 0.76 CYP2C19 (0.60) CYP2C19CYP1A2CYP3A4CYP2C9THPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3897652-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS KSQ Therapeutics, Inc. (US) 2021-10-27 EP disclosed
WO-2020132269-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS KSQ Therapeutics, Inc. (US) 2020-06-25 WO disclosed